Tags

Type your tag names separated by a space and hit enter

Intraoperative ICG-fluorescence imaging for robotic-assisted urologic surgery: current status and review of literature.
Int Urol Nephrol 2019; 51(5):765-771IU

Abstract

PURPOSE

With the availability of near-infrared fluorescence (NIRF) imaging using indocyanine green dye (ICG) to the robotic platform, utility of this imaging technology has evolved significantly across the board for ablative and reconstructive procedures. Herein, we describe the potential indications of indocyanine green for both oncologic and non-oncologic applications in robot-assisted laparoscopic urologic surgery.

METHODS

A narrative mini-review was performed in November 2018 using PubMed, Scopus, EMBASE, and Web of Science databases utilizing the following search phrase: "indocyanine green fluorescence robotic surgery" resulting in 104 articles of which 30 articles had urologic-pertinent applications. All 30 articles, and the references within, were reviewed and judged for scientific integrity and merit. Articles with non-novel findings or similar conclusions to original papers were omitted.

RESULTS

ICG does not have a urologic FDA indication, though it has been used off-label for urologic surgery since 2006. Fluorescence-augmented surgery with ICG can facilitate oncologic surgery in the adrenal gland, kidney, bladder, prostate, and retroperitoneum, in addition to lymph node dissection for various malignant pathologies. ICG-NIRF can enhance non-oncologic surgery including ureterolysis, ureteroureterostomy, ureteral re-implantation, pyeloplasty, and urinary diversion in both the adult and pediatric populations.

CONCLUSIONS

Although it is not necessary to utilize fluorescence-enhanced surgery in all cases, the authors find the utilization of ICG-NIRF in complex and highly technical surgeries useful.

Authors+Show Affiliations

Department of Urology, Wake Forest Baptist Medical Center, Winston-Salem, NC, 27157-1094, USA.Department of Urology, Wake Forest Baptist Medical Center, Winston-Salem, NC, 27157-1094, USA. ahemal@wakehealth.edu.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

30903392

Citation

Pathak, Ram A., and Ashok K. Hemal. "Intraoperative ICG-fluorescence Imaging for Robotic-assisted Urologic Surgery: Current Status and Review of Literature." International Urology and Nephrology, vol. 51, no. 5, 2019, pp. 765-771.
Pathak RA, Hemal AK. Intraoperative ICG-fluorescence imaging for robotic-assisted urologic surgery: current status and review of literature. Int Urol Nephrol. 2019;51(5):765-771.
Pathak, R. A., & Hemal, A. K. (2019). Intraoperative ICG-fluorescence imaging for robotic-assisted urologic surgery: current status and review of literature. International Urology and Nephrology, 51(5), pp. 765-771. doi:10.1007/s11255-019-02126-0.
Pathak RA, Hemal AK. Intraoperative ICG-fluorescence Imaging for Robotic-assisted Urologic Surgery: Current Status and Review of Literature. Int Urol Nephrol. 2019;51(5):765-771. PubMed PMID: 30903392.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Intraoperative ICG-fluorescence imaging for robotic-assisted urologic surgery: current status and review of literature. AU - Pathak,Ram A, AU - Hemal,Ashok K, Y1 - 2019/03/22/ PY - 2018/12/25/received PY - 2019/03/07/accepted PY - 2019/3/25/pubmed PY - 2019/3/25/medline PY - 2019/3/24/entrez KW - Adrenalectomy KW - Cystectomy KW - ICG KW - Kidney KW - Laparoscopy KW - Molecular guided KW - Nephroureterectomy KW - Partial nephrectomy KW - Prostatectomy KW - Pyeloplasty KW - Reconstruction KW - Robot KW - Robotic KW - Ureter KW - Urinary diversion SP - 765 EP - 771 JF - International urology and nephrology JO - Int Urol Nephrol VL - 51 IS - 5 N2 - PURPOSE: With the availability of near-infrared fluorescence (NIRF) imaging using indocyanine green dye (ICG) to the robotic platform, utility of this imaging technology has evolved significantly across the board for ablative and reconstructive procedures. Herein, we describe the potential indications of indocyanine green for both oncologic and non-oncologic applications in robot-assisted laparoscopic urologic surgery. METHODS: A narrative mini-review was performed in November 2018 using PubMed, Scopus, EMBASE, and Web of Science databases utilizing the following search phrase: "indocyanine green fluorescence robotic surgery" resulting in 104 articles of which 30 articles had urologic-pertinent applications. All 30 articles, and the references within, were reviewed and judged for scientific integrity and merit. Articles with non-novel findings or similar conclusions to original papers were omitted. RESULTS: ICG does not have a urologic FDA indication, though it has been used off-label for urologic surgery since 2006. Fluorescence-augmented surgery with ICG can facilitate oncologic surgery in the adrenal gland, kidney, bladder, prostate, and retroperitoneum, in addition to lymph node dissection for various malignant pathologies. ICG-NIRF can enhance non-oncologic surgery including ureterolysis, ureteroureterostomy, ureteral re-implantation, pyeloplasty, and urinary diversion in both the adult and pediatric populations. CONCLUSIONS: Although it is not necessary to utilize fluorescence-enhanced surgery in all cases, the authors find the utilization of ICG-NIRF in complex and highly technical surgeries useful. SN - 1573-2584 UR - https://www.unboundmedicine.com/medline/citation/30903392/Intraoperative_ICG-fluorescence_imaging_for_robotic-assisted_urologic_surgery:_current_status_and_review_of_literature L2 - https://doi.org/10.1007/s11255-019-02126-0 DB - PRIME DP - Unbound Medicine ER -